IQV · News · 20260805N

Acquisition / Partnership / Divestiture

IQVIA HOLDINGS INC. · 2026-08-05 · Importance 31 · Surprise 42

IQVIA announced a strategic collaboration with Medera Inc. to advance cardiac gene therapies and human-based drug discovery. IQVIA will contribute clinical-trial infrastructure, while Medera will contribute its gene-therapy platform and cardiovascular drug-development capabilities. The collaboration expands IQVIA’s involvement in gene therapy and innovative drug development without a disclosed transaction value. The partnership is intended to accelerate cardiac gene-therapy development and human-based discovery programs.

Key facts

• Institutional investors collectively hold 89.62% of IQVIA's stock. source
• Bank of America Corp DE reduced its stake in IQVIA by 6.9% in the first quarter, selling 96,756 shares and retaining 1.30 million shares valued at over $221 million. source
• First Trust Advisors LP cut its stake in IQVIA by 55.4% in the undefined quarter and owned 28,023 shares after selling 34,759 shares. source